| Factor Information | |
|---|---|
| Data ID | 1420 |
| Factor | metabolic syndrome criteria met(after matched control) |
| Description | Within the matched cohorts, 15.0% ACHD patients met International Diabetes Foundation criteria for metabolic syndrome versus 7.4% of control patients. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | prevalence with metabolic syndrome in ACHD |
| p Value | 0.002 |
| OR | 1.82 |
| Conclusion | After adjustment for age and sex, metablic syndrome was more common in ACHD patients than in all control patients. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 527 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
| Reference | |
|---|---|
| PMID | 26873680 |
| Year | 2016 |
| Title | Metabolic Syndrome in Adults With Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | Washington,USA | |
| Method | Pearson χ 2 test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | ACHD(Treatment) | control(Control) |
| Number | 67 | 33 |
| Age | 38 years | 39 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 67(15%) | 33(7.4%) |
